Puma Biotechnology

PBYI

Börsenwert 507 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Camber Capital Management Boston, Massachusetts	11,1 Mio. $	–	–	–
2	2 Vanguard Group Malvern, Pennsylvania	9,9 Mio. $	+28.140 $	+8.262	+0,2 %
3	3 Millennium Management New York	8,11 Mio. $	+943.758 $	+277.095	+10 %
4	4 Acadian Asset Management Boston, Massachusetts	4,88 Mio. $	-54.913 $	-16.123	-0,9 %
5	ACM 5 Athyrium Capital Management New York	4,71 Mio. $	–	–	–
6	6 Renaissance Technologies New York	4,54 Mio. $	-106.983 $	-31.411	-2 %
7	7 Eversept Partners New York	4,42 Mio. $	+78.179 $	+22.954	+1 %
8	8 BlackRock New York	3,88 Mio. $	-141.665 $	-41.594	-3 %
9	9 Globeflex Capital San Diego, California	1,42 Mio. $	-78.237 $	-22.971	-4 %
10	10 Dimensional Fund Advisors Austin, Texas	1,26 Mio. $	+167.580 $	+49.203	+11 %
11	KCM 11 Kynam Capital Management Princeton, New Jersey	1,25 Mio. $	+3.082 $	+905	+0,2 %
12	12 Geode Capital Management Boston, Massachusetts	1,12 Mio. $	+99.176 $	+29.119	+7 %
13	13 Rice Hall James & Associates San Diego, California	956.442 $	-25.095 $	-7.368	-2 %
14	14 Morgan Stanley New York	891.100 $	+51.831 $	+15.218	+5 %
15	15 SEI Investments Oaks, Pennsylvania	751.276 $	+201 $	+59	+0 %
16	16 GSA Capital Partners London, United Kingdom	735.000 $	+561.738 $	+164.931	+144 %
17	17 Two Sigma Advisers New York	683.274 $	-288.820 $	-84.800	-25 %
18	18 Marshall Wace London, United Kingdom	563.380 $	-36.034 $	-10.580	-5 %
19	19 Affinity Asset Advisors New York	532.178 $	–	–	–
20	20 Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada	525.387 $	–	–	–
21	21 Federated Hermes Pittsburgh, Pennsylvania	478.505 $	–	–	–
22	22 Citadel Advisors Miami, Florida	473.697 $	-133.930 $	-39.323	-18 %
23	23 State Street Boston, Massachusetts	427.328 $	-13.951 $	-4.096	-2 %
24	24 Bridgeway Capital Management Houston, Texas	390.292 $	–	–	–
25	25 Prospera Financial Services Dallas, Texas	323.184 $	+49.195 $	+14.444	+13 %

Puma Biotechnology PBYI Börsenwert 507 Mio. $

Puma Biotechnology

PBYI

Börsenwert 507 Mio. $